Global Antibiotics Market is expected to reach $67.36 billion by 2028 growing at a CAGR of 6.5% during 2020 to 2028.
Some of the key players profiled in the Antibiotics Market include Abbott Laboratories, AbbVie Inc., Astellas Pharma, AstraZeneca Plc, Bayer AG, Daiichi Sankyo, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Melinta Therapeutics Inc., Merck KGaA, Pfizer Inc. and Sanofi.
The rising prevalence of infectious diseases, supportive government legislation and the expanding vulnerable aging population are driving the market growth. However, some issues associated with antibiotics, such as antibiotic resistance and lengthy and tedious regulatory procedures is hampering the growth of the market.
Request for sample here: https://www.strategymrc.com/report/antibiotics-market/request-sample
Antibiotic is a medication used to either inhibit or prevent bacterial infections referred as bactericidal and bacteriostatic antibiotics, respectively. Various types of antibiotics such as penicillin, cephalosporin, carbapenem, and monobactam are available in pharmacies and hospitals that are used to treat infectious diseases.
Based on the drug class, the penicillin segment is going to have lucrative growth during the forecast period due to maximum prescription and the largest number of generic manufacturers in the space.
Access the complete report at: https://www.strategymrc.com/report/antibiotics-market
By geography, Asia Pacific is going to have high growth during the forecast period owing to the high consumption of antibiotics, increase in the prevalence of infectious diseases, and rising government initiatives to develop novel therapies to treat drug-resistant infections in the region.
Make an inquiry at: https://www.strategymrc.com/report/antibiotics-market
Action Mechanisms Covered:
• Cell Wall Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Protein Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Broad Spectrum
• Narrow Spectrum
Route of Administrations Covered:
• Blood Stream Infections
• Clostridium Difficile Infections
• Intra-Abdominal Infections
• Urinary Tract Infection
Drug Classes Covered:
• Beta Lactam &Beta Lactamase Inhibitors
• Monoclonal Antibodies
End Users Covered:
• Specialty Clinics
• Research Organizations
Distribution Channels Covered:
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Follow us on Twitter: https://twitter.com/StratisticsMRC
Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile
About Stratistics MRC
We offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services, and Full-Time Equivalent (FTE) services in the research world. We explore market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.
Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.